Approvals/CIMA-AEMPS/FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 5165783f53890de7
Drug Cima Aemps Name: FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL
Register Number: R-2948IP2
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2023-07-31
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 0,05 mg fluticasona propionato
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

FLUTICASONA PROPIONATO

0,05 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 31, 2023

Approval ID

5165783f53890de7

Type

Standard